These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25311850)

  • 21. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study.
    Bai AD; Showler A; Burry L; Steinberg M; Ricciuto DR; Fernandes T; Chiu A; Raybardhan S; Science M; Fernando E; Tomlinson G; Bell CM; Morris AM
    J Antimicrob Chemother; 2015 May; 70(5):1539-46. PubMed ID: 25614044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis.
    Yetmar ZA; Razi S; Nayfeh T; Gerberi DJ; Mahmood M; Abu Saleh OM
    Int J Antimicrob Agents; 2022 Jan; 59(1):106486. PubMed ID: 34839007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?
    Paul M; Zemer-Wassercug N; Talker O; Lishtzinsky Y; Lev B; Samra Z; Leibovici L; Bishara J
    Clin Microbiol Infect; 2011 Oct; 17(10):1581-6. PubMed ID: 21073629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the vancomycin minimum inhibitory concentration on clinical outcomes in patients with methicillin-susceptible
    Shi C; Ye J; Xu R; Jin W; Xu S; Teng F; Lin N
    BMJ Open; 2021 Jan; 11(1):e040675. PubMed ID: 33452189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of cloxacillin versus cefazolin for methicillin-susceptible
    Burdet C; Loubet P; Le Moing V; Vindrios W; Esposito-Farèse M; Linard M; Ferry T; Massias L; Tattevin P; Wolff M; Vandenesch F; Grall N; Quintin C; Mentré F; Duval X; Lescure FX;
    BMJ Open; 2018 Sep; 8(8):e023151. PubMed ID: 30173161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.
    Lee S; Song KH; Jung SI; Park WB; Lee SH; Kim YS; Kwak YG; Kim YK; Kiem SM; Kim HI; Kim ES; Park KH; Kim NJ; Jang HC; Kim HB;
    Clin Microbiol Infect; 2018 Feb; 24(2):152-158. PubMed ID: 28694202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study.
    Braquet P; Alla F; Cornu C; Goehringer F; Piroth L; Chirouze C; Revest M; Lechiche C; Duval X; Le Moing V;
    Clin Microbiol Infect; 2016 Nov; 22(11):948.e1-948.e7. PubMed ID: 27515395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature.
    Polenakovik HM; Pleiman CM
    Int J Antimicrob Agents; 2013 Nov; 42(5):450-5. PubMed ID: 23993067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefazolin versus cloxacillin as definitive antibiotic therapy for methicillin-susceptible Staphylococcus aureus spinal epidural abscess: a retrospective cohort study.
    Bai AD; Findlater A; Irfan N; Singhal N; Loeb M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106429. PubMed ID: 34469802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia.
    Monogue ML; Ortwine JK; Wei W; Eljaaly K; Bhavan KP
    J Infect Public Health; 2018; 11(5):727-731. PubMed ID: 29526442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia.
    Tsai CY; Lee CH; Chen IL
    BMC Infect Dis; 2021 May; 21(1):437. PubMed ID: 33980167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
    Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
    Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia.
    Gudiol C; Cuervo G; Shaw E; Pujol M; Carratalà J
    Expert Opin Pharmacother; 2017 Dec; 18(18):1947-1963. PubMed ID: 29115883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections.
    Miller MA; Fish DN; Barber GR; Barron MA; Goolsby TA; Moine P; Mueller SW
    J Microbiol Immunol Infect; 2020 Apr; 53(2):321-327. PubMed ID: 30190234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms.
    González C; Rubio M; Romero-Vivas J; González M; Picazo JJ
    Clin Infect Dis; 1999 Nov; 29(5):1171-7. PubMed ID: 10524959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
    Melzer M; Eykyn SJ; Gransden WR; Chinn S
    Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftriaxone versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia.
    Mohamed A; Bennett N; Ploetz J; Aragon L; Kennedy K; Boyd S
    Int J Antimicrob Agents; 2022 Sep; 60(3):106632. PubMed ID: 35787919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.
    McDanel JS; Perencevich EN; Diekema DJ; Herwaldt LA; Smith TC; Chrischilles EA; Dawson JD; Jiang L; Goto M; Schweizer ML
    Clin Infect Dis; 2015 Aug; 61(3):361-7. PubMed ID: 25900170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flucloxacillin and cefazolin for treatment of Staphylococcus aureus bloodstream infection.
    Schmidt-Hellerau K; Breuninger M; Kessel J; Vehreschild MJGT; Paul G; Reusch J; Jung N; Hellmich M; Fätkenheuer G
    Infection; 2024 Jun; 52(3):1159-1163. PubMed ID: 38296936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empirical use of β-lactam/β-lactamase inhibitor combinations does not increase mortality compared with cloxacillin and cefazolin in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-weighted cohort study.
    Willekens R; Puig-Asensio M; Suanzes P; Fernández-Hidalgo N; Larrosa MN; González-López JJ; Rodríguez-Pardo D; Pigrau C; Almirante B
    J Antimicrob Chemother; 2022 Jul; 77(8):2288-2295. PubMed ID: 35552420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.